1. Home
  2. ADAP vs MOB Comparison

ADAP vs MOB Comparison

Compare ADAP & MOB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADAP
  • MOB
  • Stock Information
  • Founded
  • ADAP 2008
  • MOB 2008
  • Country
  • ADAP United Kingdom
  • MOB Israel
  • Employees
  • ADAP N/A
  • MOB N/A
  • Industry
  • ADAP Biotechnology: Pharmaceutical Preparations
  • MOB Real Estate Investment Trusts
  • Sector
  • ADAP Health Care
  • MOB Real Estate
  • Exchange
  • ADAP Nasdaq
  • MOB Nasdaq
  • Market Cap
  • ADAP 21.3M
  • MOB 24.1M
  • IPO Year
  • ADAP 2015
  • MOB 2022
  • Fundamental
  • Price
  • ADAP $0.06
  • MOB $4.73
  • Analyst Decision
  • ADAP Hold
  • MOB
  • Analyst Count
  • ADAP 6
  • MOB 0
  • Target Price
  • ADAP $1.02
  • MOB N/A
  • AVG Volume (30 Days)
  • ADAP 89.0M
  • MOB 345.8K
  • Earning Date
  • ADAP 08-13-2025
  • MOB 08-12-2025
  • Dividend Yield
  • ADAP N/A
  • MOB N/A
  • EPS Growth
  • ADAP N/A
  • MOB N/A
  • EPS
  • ADAP N/A
  • MOB N/A
  • Revenue
  • ADAP $65,084,999.00
  • MOB $2,826,361.00
  • Revenue This Year
  • ADAP N/A
  • MOB N/A
  • Revenue Next Year
  • ADAP $52.35
  • MOB N/A
  • P/E Ratio
  • ADAP N/A
  • MOB N/A
  • Revenue Growth
  • ADAP N/A
  • MOB N/A
  • 52 Week Low
  • ADAP $0.05
  • MOB $0.85
  • 52 Week High
  • ADAP $1.33
  • MOB $5.00
  • Technical
  • Relative Strength Index (RSI)
  • ADAP 29.42
  • MOB 66.66
  • Support Level
  • ADAP $0.05
  • MOB $3.62
  • Resistance Level
  • ADAP $0.09
  • MOB $4.59
  • Average True Range (ATR)
  • ADAP 0.01
  • MOB 0.45
  • MACD
  • ADAP 0.00
  • MOB 0.05
  • Stochastic Oscillator
  • ADAP 7.21
  • MOB 95.27

About ADAP Adaptimmune Therapeutics plc

Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70, and others for multiple cancer types.

About MOB Mobilicom Limited

Mobilicom Ltd is a provider of cybersecurity and smart solutions for drones, robotics & autonomous platforms. As a high-tech company, it designs, develops, and delivers smart solutions targeting global drone, robotics, and autonomous system manufacturers. Its products include OS3 Platform Software, ICE Cybersecurity Software, MCU Mesh Networking, SkyHopper Datalinks, Mobile Ground Control Stations and System Engineering Services.

Share on Social Networks: